In conclusion, we reveal a distinct molecular mechanism by which SFTSV-induced sVEGFR1 release via upregulated EGR1 contributes to hemorrhage, suggesting that SFTSV infection disrupts the balance between the pro-angiogenic and anti-angiogenic state. The gene discussed is EGR1; the disease is hemorrhage.